Daly James M
Insider CIK 1560782 · CYTK Director · ACAD Director · CMRX Director · MDGL Director · HALO Director · BLCM Director · INCY Exec. VP & Chief Comm. Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYTK CYTOKINETICS INC | A Award | 2026-10-16 | 2026-10-20 | 195 | $63.92 | $12.5K | 3,585 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-10-01 | 2026-10-02 | 1,775 | — | $0 | 1,775 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-10-01 | 2026-10-02 | 1,169 | — | $0 | 1,169 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-07-15 | 2026-07-16 | 151 | $82.62 | $12.5K | 3,390 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-06-17 | 2026-06-18 | 766 | — | $0 | 766 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-18 | 454 | — | $0 | 3,081 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 16,004 | — | $0 | 16,004 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-05-29 | 2026-06-01 | 8,107 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 9,311 | — | $0 | 9,311 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-05-29 | 2026-06-01 | 8,107 | — | $0 | 12,148 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 3,239 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-04-15 | 2026-04-15 | 191 | $65.37 | $12.5K | 388 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-01-15 | 2026-01-20 | 197 | $63.44 | $12.5K | 197 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2025-11-10 | 2025-11-12 | 30,000 | $22.37 | $671.1K | 4,041 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2025-08-19 | 2025-08-20 | 27,450 | — | $0 | 27,450 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-06-20 | 2025-06-24 | 1,290 | — | $0 | 1,290 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-06-20 | 2025-06-24 | 715 | — | $0 | 2,627 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 8,107 | — | $0 | 8,107 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 13,793 | — | $0 | 13,793 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 34,041 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-02-27 | 2025-02-28 | 6,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-02-27 | 2025-02-28 | 9,470 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-02-27 | 2025-02-28 | 9,470 | $65.06 | $616.1K | 11,382 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-02-27 | 2025-02-28 | 6,000 | $111.06 | $666.4K | 17,382 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 398 | $346.90 | $138.1K | 16,984 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 14,302 | $347.39 | $4.97M | 2,682 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 770 | $348.94 | $268.7K | 1,912 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-06-25 | 2024-06-27 | 1,105 | — | $0 | 1,105 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-06-25 | 2024-06-27 | 714 | — | $0 | 1,912 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 9,387 | — | $0 | 9,387 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 15,959 | — | $0 | 15,959 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 24,654 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-02 | 2024-04-03 | 10,912 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 43 | $247.03 | $10.6K | 1,398 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 557 | $246.30 | $137.2K | 1,441 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 2,991 | $244.89 | $732.5K | 1,998 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 6,279 | $244.19 | $1.53M | 4,989 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 842 | $243.26 | $204.8K | 11,268 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-02 | 2024-04-03 | 10,912 | $105.08 | $1.15M | 12,110 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 200 | $248.45 | $49.7K | 1,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,577 | — | $0 | 10,912 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 20,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 1,577 | $105.08 | $165.7K | 22,775 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 274 | $266.91 | $73.1K | 1,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 500 | $265.49 | $132.7K | 1,472 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 351 | $264.89 | $93.0K | 1,972 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 178 | $263.31 | $46.9K | 2,323 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 800 | $262.01 | $209.6K | 2,501 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 200 | $259.11 | $51.8K | 3,301 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 1,460 | $258.28 | $377.1K | 3,501 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 3,604 | $257.30 | $927.3K | 4,961 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 7,401 | $256.50 | $1.90M | 8,565 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 6,809 | $255.64 | $1.74M | 15,966 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 20,000 | $100.45 | $2.01M | 21,198 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2023-08-14 | 2023-08-15 | 10,000 | $43.74 | $437.4K | 20,503 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2023-08-11 | 2023-08-15 | 10,000 | $43.71 | $437.1K | 30,503 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-06-15 | 2023-06-20 | 1,198 | — | $0 | 1,198 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 11,045 | — | $0 | 11,045 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 6,652 | — | $0 | 6,652 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 18,002 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2023-05-05 | 2023-05-09 | 11,371 | — | $0 | 11,371 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2023-05-05 | 2023-05-09 | 8,065 | — | $0 | 40,503 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-05 | 60,414 | — | $0 | 109,873 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2022-09-02 | 35,082 | — | $0 | 49,459 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-21 | 9,470 | — | $0 | 9,470 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 9,450 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 14,368 | — | $0 | 14,368 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 8,552 | — | $0 | 8,552 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2022-05-05 | 2022-05-06 | 6,206 | — | $0 | 32,438 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-01-06 | 13,568 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-01-06 | 809 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-01-06 | 13,568 | — | $0 | 13,568 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-01-06 | 809 | — | $0 | 14,377 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-07-01 | 2021-07-06 | 809 | — | $0 | 809 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 3,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 6,391 | — | $0 | 6,391 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 11,637 | — | $0 | 11,637 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-06-17 | 2021-06-21 | 12,489 | — | $0 | 12,489 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-06-15 | 2021-07-07 | 6,500 | — | $0 | 6,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2021-05-05 | 2021-05-06 | 5,230 | — | $0 | 26,232 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 13,568 | — | $0 | 13,568 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2020-11-25 | 2020-11-25 | 10,363 | $40.41 | $418.8K | 21,002 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2020-08-13 | 2020-08-13 | 34,337 | $29.12 | $999.9K | 31,365 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 3,059 | — | $0 | 3,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 5,579 | — | $0 | 5,579 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-06-15 | 2020-06-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-05-11 | 2020-05-13 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-05-11 | 2020-05-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-05-11 | 2020-05-13 | 11,250 | $25.24 | $283.9K | 11,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-05-11 | 2020-05-13 | 15,000 | $27.25 | $408.8K | 26,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-11 | 2020-05-13 | 26,250 | $51.13 | $1.34M | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2020-04-30 | 2020-05-01 | 8,829 | — | $0 | 65,702 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-09-09 | 2019-09-11 | 30,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-09-09 | 2019-09-11 | 400 | $38.39 | $15.4K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-09-09 | 2019-09-11 | 29,600 | $37.79 | $1.12M | 400 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-09-09 | 2019-09-11 | 30,000 | $17.52 | $525.6K | 30,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-06-26 | 2019-06-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2019-06-20 | 2019-06-24 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2019-05-02 | 2019-05-03 | 12,173 | — | $0 | 56,873 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-06-20 | 2018-06-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2018-05-02 | 2018-05-02 | 10,363 | — | $0 | 44,700 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-07-17 | 2017-07-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2017-06-28 | 2017-06-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-06-14 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2017-05-04 | 2017-05-05 | 14,135 | — | $0 | 34,337 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2016-06-24 | 2016-06-28 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2016-06-10 | 2016-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-05-17 | 2016-05-19 | 833 | — | $0 | 833 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-05-17 | 2016-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2016-05-04 | 2016-05-06 | 20,202 | — | $0 | 20,202 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2016-01-07 | 2016-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-23 | 2015-06-25 | 7,331 | — | $0 | 30,928 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-23 | 2015-06-25 | 2,778 | — | $0 | 16,765 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-23 | 2015-06-25 | 981 | — | $0 | 17,662 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-23 | 2015-06-25 | 601 | — | $0 | 2,407 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-23 | 2015-06-25 | 601 | $16.62 | $10.0K | 14,231 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-23 | 2015-06-25 | 7,331 | $16.62 | $121.8K | 13,630 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-23 | 2015-06-25 | 2,778 | $18.32 | $50.9K | 6,299 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-06-23 | 2015-06-25 | 981 | $107.84 | $105.8K | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-23 | 2015-06-25 | 981 | $64.55 | $63.3K | 4,502 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-06-23 | 2015-06-25 | 10,710 | $108.28 | $1.16M | 3,521 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2015-06-22 | 2015-06-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-26 | 2015-05-28 | 7,732 | — | $0 | 38,659 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-26 | 2015-05-28 | 981 | — | $0 | 18,643 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-26 | 2015-05-28 | 602 | — | $0 | 3,008 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-26 | 2015-05-28 | 2,778 | — | $0 | 19,543 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-26 | 2015-05-28 | 7,732 | $16.62 | $128.5K | 14,031 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-26 | 2015-05-28 | 2,778 | $18.32 | $50.9K | 6,299 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-26 | 2015-05-28 | 602 | $16.62 | $10.0K | 14,633 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-26 | 2015-05-28 | 981 | $64.55 | $63.3K | 4,502 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 981 | $106.00 | $104.0K | 3,521 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 11,112 | $106.43 | $1.18M | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-23 | 2015-04-24 | 14,718 | — | $0 | 19,624 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-23 | 2015-04-24 | 5,556 | — | $0 | 22,321 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-23 | 2015-04-24 | 15,464 | — | $0 | 46,391 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-23 | 2015-04-24 | 1,203 | — | $0 | 3,610 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-23 | 2015-04-24 | 14,718 | $64.55 | $950.0K | 18,239 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-04-23 | 2015-04-24 | 22,223 | $107.67 | $2.39M | 3,521 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-04-23 | 2015-04-24 | 14,718 | $107.67 | $1.58M | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-23 | 2015-04-24 | 15,464 | $16.62 | $257.0K | 20,188 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-23 | 2015-04-24 | 1,203 | $16.62 | $20.0K | 4,724 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-23 | 2015-04-24 | 5,556 | $18.32 | $101.8K | 25,744 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-24 | 2015-02-25 | 7,732 | — | $0 | 61,855 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-24 | 2015-02-25 | 602 | — | $0 | 4,813 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-24 | 2015-02-25 | 7,732 | $16.62 | $128.5K | 11,253 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-24 | 2015-02-25 | 602 | $16.62 | $10.0K | 11,855 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-24 | 2015-02-25 | 8,334 | $81.77 | $681.5K | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-23 | 2015-02-25 | 2,778 | — | $0 | 27,877 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-23 | 2015-02-25 | 2,778 | $83.44 | $231.8K | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-23 | 2015-02-25 | 2,778 | $18.32 | $50.9K | 6,299 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-01-23 | 2015-01-26 | 7,731 | — | $0 | 69,587 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-01-23 | 2015-01-26 | 601 | — | $0 | 5,415 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-01-23 | 2015-01-26 | 2,777 | — | $0 | 30,655 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-01-23 | 2015-01-26 | 11,109 | $77.68 | $862.9K | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-01-23 | 2015-01-26 | 7,731 | $16.62 | $128.5K | 11,252 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-01-23 | 2015-01-26 | 601 | $16.62 | $10.0K | 11,853 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-01-23 | 2015-01-26 | 2,777 | $18.32 | $50.9K | 14,630 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 1,099 | — | $0 | 1,099 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 20,446 | — | $0 | 20,446 | SEC↗ |
| INCY INCYTE CORP | A Award | 2015-01-08 | 2015-01-09 | 3,022 | — | $0 | 3,521 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-12-23 | 2014-12-29 | 502 | — | $0 | 6,016 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-12-23 | 2014-12-29 | 7,833 | — | $0 | 77,318 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-12-23 | 2014-12-29 | 2,778 | — | $0 | 33,432 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-12-23 | 2014-12-29 | 7,833 | $16.62 | $130.2K | 10,611 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-12-23 | 2014-12-29 | 11,113 | $74.43 | $827.1K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-12-23 | 2014-12-29 | 502 | $16.62 | $8.3K | 11,113 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-12-23 | 2014-12-29 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-24 | 2014-11-26 | 2,778 | — | $0 | 36,210 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-24 | 2014-11-26 | 501 | — | $0 | 6,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-24 | 2014-11-26 | 7,832 | — | $0 | 85,151 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-24 | 2014-11-26 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-24 | 2014-11-26 | 501 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-11-24 | 2014-11-26 | 11,111 | $74.08 | $823.1K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-24 | 2014-11-26 | 7,832 | $16.62 | $130.2K | 10,610 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-10-23 | 2014-10-24 | 501 | — | $0 | 7,019 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-10-23 | 2014-10-24 | 2,778 | — | $0 | 38,988 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-10-23 | 2014-10-24 | 7,832 | — | $0 | 92,983 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-10-23 | 2014-10-24 | 501 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-10-23 | 2014-10-24 | 7,832 | $16.62 | $130.2K | 10,610 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-10-23 | 2014-10-24 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-10-23 | 2014-10-24 | 11,111 | $53.49 | $594.3K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-09-23 | 2014-09-25 | 2,777 | — | $0 | 41,766 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-09-23 | 2014-09-25 | 7,832 | — | $0 | 100,815 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-09-23 | 2014-09-25 | 502 | — | $0 | 7,520 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-09-23 | 2014-09-25 | 2,777 | $18.32 | $50.9K | 2,777 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-09-23 | 2014-09-25 | 11,111 | $47.65 | $529.4K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-09-23 | 2014-09-25 | 502 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-09-23 | 2014-09-25 | 7,832 | $16.62 | $130.2K | 10,609 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-08-25 | 2014-08-27 | 2,778 | — | $0 | 44,543 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-08-25 | 2014-08-27 | 7,832 | — | $0 | 108,647 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-08-25 | 2014-08-27 | 501 | — | $0 | 8,022 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-08-25 | 2014-08-27 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-08-25 | 2014-08-27 | 7,832 | $16.62 | $130.2K | 10,610 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-08-25 | 2014-08-27 | 11,111 | $51.96 | $577.3K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-08-25 | 2014-08-27 | 501 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-07-23 | 2014-07-25 | 7,832 | — | $0 | 116,479 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-07-23 | 2014-07-25 | 2,778 | — | $0 | 47,231 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-07-23 | 2014-07-25 | 501 | — | $0 | 8,523 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-07-23 | 2014-07-25 | 501 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-07-23 | 2014-07-25 | 7,832 | $16.62 | $130.2K | 10,610 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-07-23 | 2014-07-25 | 11,111 | $48.54 | $539.3K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-07-23 | 2014-07-25 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-23 | 2014-06-25 | 502 | — | $0 | 9,024 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-23 | 2014-06-25 | 7,832 | — | $0 | 124,311 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-23 | 2014-06-25 | 2,777 | — | $0 | 50,099 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-23 | 2014-06-25 | 7,832 | $16.62 | $130.2K | 7,832 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-23 | 2014-06-25 | 502 | $16.62 | $8.3K | 8,334 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-06-23 | 2014-06-25 | 8,334 | $55.92 | $466.0K | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-06-23 | 2014-06-25 | 2,777 | $56.38 | $156.6K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-23 | 2014-06-25 | 2,777 | $18.32 | $50.9K | 2,777 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-06-20 | 2014-06-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-06-20 | 2014-06-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-05-23 | 2014-05-28 | 7,832 | — | $0 | 132,143 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-05-23 | 2014-05-28 | 501 | — | $0 | 9,526 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-05-23 | 2014-05-28 | 2,778 | — | $0 | 52,876 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-05-23 | 2014-05-28 | 501 | $16.62 | $8.3K | 11,111 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-05-23 | 2014-05-28 | 2,778 | $18.32 | $50.9K | 2,778 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-05-23 | 2014-05-28 | 11,111 | $48.48 | $538.7K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-05-23 | 2014-05-28 | 7,832 | $16.62 | $130.2K | 10,610 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 23,496 | — | $0 | 139,975 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 5,555 | — | $0 | 55,654 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 1,504 | — | $0 | 10,027 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-04-23 | 2014-04-25 | 1,504 | $16.62 | $25.0K | 30,555 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-04-23 | 2014-04-25 | 5,555 | $18.32 | $101.8K | 5,555 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-04-23 | 2014-04-25 | 23,496 | $16.62 | $390.5K | 29,051 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-04-23 | 2014-04-25 | 30,555 | $47.71 | $1.46M | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 118,481 | — | $0 | 163,471 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 6,517 | — | $0 | 11,531 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 33,333 | — | $0 | 61,209 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 118,481 | $16.62 | $1.97M | 158,331 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-13 | 2014-02-18 | 158,331 | $66.49 | $10.53M | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 33,333 | $18.32 | $610.7K | 33,333 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 6,517 | $16.62 | $108.3K | 39,850 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 34,342 | — | $0 | 34,342 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 982 | — | $0 | 982 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 94,542 | — | $0 | 94,542 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 5,458 | — | $0 | 5,458 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2012-10-22 | 2012-10-23 | 18,048 | — | $0 | 18,048 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2012-10-22 | 2012-10-23 | 281,952 | — | $0 | 281,952 | SEC↗ |